Abdominal Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Abdominal Aortic Stent Grafts Pipeline Products Market Report Overview

Abdominal aortic stent grafts are used to treat abdominal aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. The Abdominal Aortic Stent Grafts pipeline market research report provides comprehensive information about the Abdominal Aortic Stent Grafts pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Abdominal Aortic Stent Grafts Pipeline Products Market Segmentation by Territories

Some of the key territories with products in the pipeline are the US, Europe, Japan, China, Colombia, Costa Rica, Ecuador, Israel, Australia, and Canada. As of February 2023, the US has the highest number of products in the pipeline out of them all.

Abdominal Aortic Stent Grafts Pipeline Products Market Analysis, by Territories, 2023 (%)

Abdominal Aortic Stent Grafts Pipeline Products Market Analysis, by Territories, 2023 (%)

 For more territory insights into the Abdominal Aortic Stent Grafts pipeline products market, download a free report sample

 

Abdominal Aortic Stent Grafts Pipeline Products Market Segmentation by Regulatory Paths

The key regulatory paths followed by the Abdominal Aortic Stent Grafts pipeline products market are PMA, CE, Shonin, NMPA, TGA, INVIMA, and MDL. Most of the products follow the PMA pathway to enter the market.

Abdominal Aortic Stent Grafts Pipeline Products Market Analysis, by Regulatory Paths, 2023 (%)

Abdominal Aortic Stent Grafts Pipeline Products Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the Abdominal Aortic Stent Grafts pipeline products market, download a free report sample

Abdominal Aortic Stent Grafts Pipeline Products Market - Competitive Landscape

Some of the leading companies in the Abdominal Aortic Stent Grafts pipeline products market are Affluent Medical SASU, Angiolutions UG, BiFlow Medical Ltd, Cook Medical Inc, Cytograft Tissue Engineering Inc (Inactive), Endologix LLC, Endoluminal Sciences Pty Ltd., Hadassah Medical Center, Johns Hopkins University, and Kawasumi Laboratories Inc.

BiFlow Medical Ltd: Headquartered in Caesarea, Israel, BiFlow is a medical device company that develops unique side-branch stent that is used for percutaneous procedures in endovascular stent grafting.

Cook Medical Inc: Headquartered in Indiana, USA, Cook Medical is a medical device company that develops, manufactures, and distributes devices for minimally invasive medicine. It offers products and services in various specialty areas including anesthesiology, bariatrics, burn surgery, cardiothoracic surgery, and colorectal surgery. The company markets products directly and through a network of distributors to physicians and hospitals across the world.

Cytograft Tissue Engineering Inc (CTE): Headquartered in California, USA, CTE is a genetic engineering company that offers therapies. CTE repairs diseased cardiovascular tissues and organs by using cells harvested from the patient and another human donor. Its technologies include thread-based tissue engineering, sheet-based tissue engineering, and particle-based tissue engineering. The company conducts clinical trials in Europe and South America.

For more insights on leading players in the Abdominal Aortic Stent Grafts pipeline products market, download a free report sample

Abdominal Aortic Stent Grafts Pipeline Products Market Report Overview

Key Territories The US, Europe, Japan, China, Colombia, Costa Rica, Ecuador, Israel, Australia, and Canada
Key Regulatory Paths PMA, CE, Shonin, NMPA, TGA, INVIMA, and MDL
Leading Companies Affluent Medical SASU, Angiolutions UG, BiFlow Medical Ltd, Cook Medical Inc, Cytograft Tissue Engineering Inc (Inactive), Endologix LLC, Endoluminal Sciences Pty Ltd., Hadassah Medical Center, Johns Hopkins University, and Kawasumi Laboratories Inc

Segments Covered in the Report

Abdominal Aortic Stent Grafts Pipeline Products Market Territories Outlook

  • The US
  • Europe
  • Japan
  • China
  • Colombia
  • Costa Rica
  • Ecuador
  • Israel
  • Australia
  • Canada

Abdominal Aortic Stent Grafts Pipeline Products Market Regulatory Paths Outlook

  • PMA
  • CE
  • Shonin
  • NMPA
  • TGA
  • INVIMA
  • MDL

Scope

This report provides:

  • Extensive coverage of the Abdominal Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of Abdominal Aortic Stent Grafts and lists all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of Abdominal Aortic Stent Grafts under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Affluent Medical SASU
Angiolutions UG
BiFlow Medical Ltd
Cook Medical Inc
Cytograft Tissue Engineering Inc (Inactive)
Endologix LLC
Endoluminal Sciences Pty Ltd.
Hadassah Medical Center
Johns Hopkins University
Kawasumi Laboratories Inc
Lombard Medical Technologies Inc.
Lombard Medical Technologies Ltd (Inactive)
Medtronic Plc
St. Jude Medical LLC
Terumo Aortic
University of Colorado Denver
University of Limerick
Venus Medtech Hangzhou Inc

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Abdominal Aortic Stent Grafts Overview

  • 3 Products under Development

    • 3.1 Abdominal Aortic Stent Grafts – Pipeline Products by Stage of Development
    • 3.2 Abdominal Aortic Stent Grafts – Pipeline Products by Territory
    • 3.3 Abdominal Aortic Stent Grafts – Pipeline Products by Regulatory Path
    • 3.4 Abdominal Aortic Stent Grafts – Pipeline Products by Estimated Approval Date
    • 3.5 Abdominal Aortic Stent Grafts – Ongoing Clinical Trials

  • 4 Abdominal Aortic Stent Grafts – Pipeline Products under Development by Companies

    • 4.1 Abdominal Aortic Stent Grafts Companies – Pipeline Products by Stage of Development
    • 4.2 Abdominal Aortic Stent Grafts – Pipeline Products by Stage of Development

  • 5 Abdominal Aortic Stent Grafts Companies and Product Overview

    • 5.1 Affluent Medical SASU Company Overview

      • 5.1.1 Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Angiolutions UG Company Overview

      • 5.2.1 Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 BiFlow Medical Ltd Company Overview

      • 5.3.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Cook Medical Inc Company Overview

      • 5.4.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Cytograft Tissue Engineering Inc (Inactive) Company Overview

      • 5.5.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Endologix LLC Company Overview

      • 5.6.1 Endologix LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Endoluminal Sciences Pty Ltd. Company Overview

      • 5.7.1 Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Hadassah Medical Center Company Overview

      • 5.8.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Johns Hopkins University Company Overview

      • 5.9.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Kawasumi Laboratories Inc Company Overview

      • 5.10.1 Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Lombard Medical Technologies Inc. Company Overview

      • 5.11.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Lombard Medical Technologies Ltd (Inactive) Company Overview

      • 5.12.1 Lombard Medical Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Medtronic Plc Company Overview

      • 5.13.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 St. Jude Medical LLC Company Overview

      • 5.14.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Terumo Aortic Company Overview

      • 5.15.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 University of Colorado Denver Company Overview

      • 5.16.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 University of Limerick Company Overview

      • 5.17.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Venus Medtech Hangzhou Inc Company Overview

      • 5.18.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Abdominal Aortic Stent Grafts- Recent Developments

    • 6.1 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president
    • 6.2 Jan 30, 2023: Medtronic India appoints Michael Blackwell as Vice President
    • 6.3 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
    • 6.4 Nov 23, 2022: Medtronic Reports Quarterly Earnings
    • 6.5 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
    • 6.6 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
    • 6.7 Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022
    • 6.8 Oct 17, 2022: LeMaitre Will Announce Third Quarter 2022 Earnings Results October 27, 2022
    • 6.9 Sep 07, 2022: Medtronic to appear at September investor conferences
    • 6.10 Aug 31, 2022: LeMaitre to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
    • 6.11 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
    • 6.12 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
    • 6.13 Jul 28, 2022: LeMaitre Q2 2022 Financial Results
    • 6.14 Jul 18, 2022: LeMaitre Will Announce Second Quarter 2022 Earnings Results July 28, 2022
    • 6.15 Jul 08, 2022: Cordis Names Bryan Loo President of Asia-pacific Region
    • 6.16 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
    • 6.17 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
    • 6.18 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
    • 6.19 Apr 28, 2022: LeMaitre Q1 2022 Financial Results
    • 6.20 Apr 15, 2022: LeMaitre Will Announce First Quarter 2022 Earnings Results April 28, 2022
    • 6.21 Apr 11, 2022: Endovastec receives MDSAP certificate for Brazil and Japan
    • 6.22 Feb 24, 2022: LeMaitre Q4 2021 Financial Results
    • 6.23 Feb 11, 2022: LeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022

  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us

Table

Abdominal Aortic Stent Grafts – Pipeline Products by Stage of Development 9

Abdominal Aortic Stent Grafts – Pipeline Products by Territory 10

Abdominal Aortic Stent Grafts – Pipeline Products by Regulatory Path 11

Abdominal Aortic Stent Grafts – Pipeline Products by Estimated Approval Date 12

Abdominal Aortic Stent Grafts – Ongoing Clinical Trials 13

Abdominal Aortic Stent Grafts Companies – Pipeline Products by Stage of Development 14

Abdominal Aortic Stent Grafts – Pipeline Products by Stage of Development 15

Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview 16

Kardiozis – Product Status 16

Kardiozis – Product Description 16

Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview 17

Vascular Graft (A3-Shield) – Product Status 17

Vascular Graft (A3-Shield) – Product Description 17

BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

Nitinol Side Branch Stent – Product Status 18

Nitinol Side Branch Stent – Product Description 18

Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Zenith Fenestrated+ Endovascular Graft – Product Status 19

Zenith Fenestrated+ Endovascular Graft – Product Description 19

Zenith P-Branch – Product Status 20

Zenith P-Branch – Product Description 20

Cook Medical Inc – Ongoing Clinical Trials Overview 21

Zenith P-Branch – Zenith p-Branch Pivotal Study 22

Zenith Fenestrated+ Endovascular Graft – Safety and Effectiveness of Surgeon-Modified Fenestrated and Branched Endografts in Treating Subjects With Complex Aortic Aneurysms 23

Zenith Fenestrated+ Endovascular Graft – Zenith Fenestrated+ Endovascular Graft Clinical Study 23

Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24

LifeJacket AAA Stent Graft – Product Status 24

LifeJacket AAA Stent Graft – Product Description 24

Endologix LLC Pipeline Products & Ongoing Clinical Trials Overview 25

AFX2 Bifurcated Endograft System – Product Status 25

AFX2 Bifurcated Endograft System – Product Description 26

AFX3 – Product Status 26

AFX3 – Product Description 26

AFX4 – Product Status 27

AFX4 – Product Description 27

Nellix 3.5 – Product Status 27

Nellix 3.5 – Product Description 28

Nellix CHEVAS – Product Status 28

Nellix CHEVAS – Product Description 28

Nellix EVAS System – Product Status 29

Nellix EVAS System – Product Description 29

Nellix With Snorkels – Product Status 29

Nellix With Snorkels – Product Description 30

Next Gen EVAS – Product Status 30

Next Gen EVAS – Product Description 30

Paravisceral System – Product Status 31

Paravisceral System – Product Description 31

Ventana 2 – Product Status 31

Ventana 2 – Product Description 32

Xpand BX Covered Stent – Product Status 32

Xpand BX Covered Stent – Product Description 32

Endologix LLC – Ongoing Clinical Trials Overview 33

Nellix EVAS System – Multicenter, Observational, Registry to Assess Outcomes of Patients Treated With the CE Marked Nellix System for Endovascular Abdominal Aortic Aneurysm Repair 34

Nellix EVAS System – Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study: EVAS 2 Confirmatory IDE Study 34

Nellix CHEVAS – Prospective, Multicenter, Non-randomized Study with Consecutive, Eligible Subject Enrollment at Each Site, for the Evaluation of the ChEVAS System for Endovascular Repair of Paravisceral, Juxtarenal, and Pararenal Abdominal Aortic Aneurysms 35

Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36

Stent-Graft With Adhesive Delivery Platform – Product Status 36

Stent-Graft With Adhesive Delivery Platform – Product Description 36

Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 37

In Situ Weldable Hybrid Stent – Product Status 37

In Situ Weldable Hybrid Stent – Product Description 37

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 38

Scaly Aortic Stent Graft – Product Status 38

Scaly Aortic Stent Graft – Product Description 38

Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Abdominal Aortic Aneurysm Stent Graft – Product Status 39

Abdominal Aortic Aneurysm Stent Graft – Product Description 39

Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

FEVAR – Product Status 40

FEVAR – Product Description 40

Lombard Medical Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41

Low Profile Stent Graft – Product Status 41

Low Profile Stent Graft – Product Description 41

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 42

Endurant Evo AAA Stent Graft System – Product Status 42

Endurant Evo AAA Stent Graft System – Product Description 42

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 43

Amplatzer AAA Vascular Graft – Product Status 43

Amplatzer AAA Vascular Graft – Product Description 43

Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 44

BoulEVARd Stent – Product Status 44

BoulEVARd Stent – Product Description 44

TREOVANCE Abdominal Stent Graft With Navitel Delivery System – Product Status 45

TREOVANCE Abdominal Stent Graft With Navitel Delivery System – Product Description 45

Terumo Aortic – Ongoing Clinical Trials Overview 46

TREOVANCE Abdominal Stent Graft With Navitel Delivery System – Anatomical Feasibility of an Off-the-shelf Scalloped Stent-graft for Infrarenal Abdominal Aneurysm with a Hostile Neck (ReSTHoNe Study) 47

University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 48

Shape Memory Polymer Arterial Stent – Product Status 48

Shape Memory Polymer Arterial Stent – Product Description 48

University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 49

Cardiovascular Graft – Product Status 49

Cardiovascular Graft – Product Description 49

Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview 50

Tumbao EndoVascular Aortic Repair System – Product Status 50

Tumbao EndoVascular Aortic Repair System – Product Description 50

Glossary 73

Figures

Abdominal Aortic Stent Grafts – Pipeline Products by Stage of Development 9

Abdominal Aortic Stent Grafts – Pipeline Products by Territory 10

Abdominal Aortic Stent Grafts – Pipeline Products by Regulatory Path 11

Abdominal Aortic Stent Grafts – Pipeline Products by Estimated Approval Date 12

Abdominal Aortic Stent Grafts – Ongoing Clinical Trials 13

Frequently asked questions

Abdominal Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Abdominal Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Abdominal Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Abdominal Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.